Thomas J Ridge
CIK 1320299 · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LOCK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
4400 NORTH POINT PARKWAY, SUITE 154
ALPHARETTA, GA 30022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYX | Director | 1,068,193 | $1.10 | $1.18M | $0 | 11 | 2026-04-02 |
| HSY | Director | 35,884 | $162.74 | $5.84M | -$30.4K | 67 | 2018-04-03 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Director | — | — | — | $0 | 2 | 2017-11-06 |
| LIFELOCK, INC. (LOCK) Delisted | Director | 38,861 | — | — | -$998.0K | 7 | 2016-05-06 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Director | 24,306 | — | — | $0 | 2 | 2016-03-04 |
| EXC | Director | 19,351 | $41.76 | $808.1K | $0 | 29 | 2014-01-02 |
| BRIGHTPOINT INC (CELL) Delisted | Director | 0 | $1.00 | $0 | $120.0K | 3 | 2012-10-16 |
| VG | Director | 89,441 | $13.16 | $1.18M | $0 | 14 | 2010-04-05 |
| HD | Director | — | $290.74 | — | $0 | 7 | 2007-05-25 |
Recent Filings · Page 4 of 15
143 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-03-04 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Grant (A) | +5,000 | $36.8K | EDGAR |
| 2016-01-05 | HSY | Grant (A) | +373 | $0 | EDGAR |
| 2015-11-06 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Grant (A) | +3,430 | $0 | EDGAR |
| 2015-10-05 | HSY | Grant (A) | +367 | $0 | EDGAR |
| 2015-07-02 | HSY | Grant (A) | +381 | $0 | EDGAR |
| 2015-05-19 | LIFELOCK, INC. (LOCK) Delisted | Grant (A) | +9,836 | $0 | EDGAR |
| 2015-05-08 | LIFELOCK, INC. (LOCK) Delisted | Grant (A) | +9,836 | $0 | EDGAR |
| 2015-04-02 | HSY | Grant (A) | +331 | $0 | EDGAR |
| 2015-01-05 | HSY | Grant (A) | +320 | $0 | EDGAR |
| 2014-10-03 | HSY | Grant (A) | +357 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.